Table 1.
Patient characteristics for groups 2 and 3.
| Patients with PPGL (n = 44) | Patients with suspected PPGL (n = 54) | |
|---|---|---|
| Age in years, mean (SD) | 51 (13.9) | 46 (15.7) |
| Sex (M/F) | 24/20 | 23/31 |
| PCC, n (%) | 20 (45) | 0 |
| sPGL, n (%) | 24 (55) | 0 |
| Metastatic PPGL, n (%) | 24 (55) | 0 |
| Germline mutation confirmed: | ||
| SDHx | 8 | 28 |
| RET | 6 | 13 |
| HIF2α | 3 | 0 |
| VHL | 1 | 11 |
| NF1 | 1 | 1 |
| MDH2 | 1 | 0 |
HIF2α, hypoxia-inducible factor-2α; MDH2, malate dehydrogenase 2; NF1, neurofibromatosis; PCC, pheochromocytoma; RET, rearranged during transfection; SDHx, succinate dehydrogenase; sPGL, sympathetic paraganglioma; VHL, von Hippel Lindau.